<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:f6c962de-b0e4-4ec3-a0a9-185100765cdd,g:cfd75c75-7849-4724-bbc5-2566ebe54f54-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="simple" xlink:href="cbio-20260331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c4fab152-37f8-4b00-a1a9-3d992ba832e1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_e3e8090a-5cd2-4514-b84e-f1449536283a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4fab152-37f8-4b00-a1a9-3d992ba832e1" xlink:to="loc_us-gaap_PreferredStockValue_e3e8090a-5cd2-4514-b84e-f1449536283a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6c035d9c-9f17-43b3-8853-48a88cd29bad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4fab152-37f8-4b00-a1a9-3d992ba832e1" xlink:to="loc_us-gaap_CommonStockValue_6c035d9c-9f17-43b3-8853-48a88cd29bad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_36e26830-e7cd-4b04-b023-df71d79bca34" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4fab152-37f8-4b00-a1a9-3d992ba832e1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_36e26830-e7cd-4b04-b023-df71d79bca34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_563e57ec-7594-431b-8b3d-dd622b5f8714" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_c4fab152-37f8-4b00-a1a9-3d992ba832e1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_563e57ec-7594-431b-8b3d-dd622b5f8714" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f533d547-46ea-4e8b-91a5-2fdd5d88d4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_579fae12-1f26-4e4c-b48a-98b998811ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f533d547-46ea-4e8b-91a5-2fdd5d88d4b0" xlink:to="loc_us-gaap_AssetsCurrent_579fae12-1f26-4e4c-b48a-98b998811ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1016c5e9-bb69-43f1-944e-64fc9f830d54" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f533d547-46ea-4e8b-91a5-2fdd5d88d4b0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1016c5e9-bb69-43f1-944e-64fc9f830d54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e795b22-ae66-4add-85af-7aa06fb8598b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f533d547-46ea-4e8b-91a5-2fdd5d88d4b0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4e795b22-ae66-4add-85af-7aa06fb8598b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_3c428cc3-50c2-4b25-9e58-f7dd6f0e28e9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f533d547-46ea-4e8b-91a5-2fdd5d88d4b0" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_3c428cc3-50c2-4b25-9e58-f7dd6f0e28e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_329c7438-a23e-4d36-a6b1-9b24da4537c1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f533d547-46ea-4e8b-91a5-2fdd5d88d4b0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_329c7438-a23e-4d36-a6b1-9b24da4537c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_694ddb70-2b33-48ff-a7c6-aff4374f092b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:to="loc_us-gaap_AccountsPayableCurrent_694ddb70-2b33-48ff-a7c6-aff4374f092b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_AccruedExpensesAndOtherAccruedLiabilitiesCurrent_3bf2273d-e554-4f30-affe-8ec9faca0731" xlink:href="cbio-20260331.xsd#cbio_AccruedExpensesAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:to="loc_cbio_AccruedExpensesAndOtherAccruedLiabilitiesCurrent_3bf2273d-e554-4f30-affe-8ec9faca0731" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1bd6e486-fea6-4e07-a280-161a3d6aefc2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1bd6e486-fea6-4e07-a280-161a3d6aefc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_34d43085-72be-434b-b04f-19dd2f46c971" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_34d43085-72be-434b-b04f-19dd2f46c971" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_ContractWithCustomerDepositLiabilityCurrent_019d3edb-b53a-7763-8e3d-789bc8cdca09" xlink:href="cbio-20260331.xsd#cbio_ContractWithCustomerDepositLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:to="loc_cbio_ContractWithCustomerDepositLiabilityCurrent_019d3edb-b53a-7763-8e3d-789bc8cdca09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019d3edb-b53a-7c6c-b70a-ae55df29314c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a26311e3-2470-4c6c-b0d2-c566e32b79f2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019d3edb-b53a-7c6c-b70a-ae55df29314c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_22cf4933-eb5e-4c3d-a969-37bdb21d10ec" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_fd04f603-5673-40cd-964b-c187885b0e61" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_22cf4933-eb5e-4c3d-a969-37bdb21d10ec" xlink:to="loc_us-gaap_LiabilitiesCurrent_fd04f603-5673-40cd-964b-c187885b0e61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_44800189-fb19-4c39-bfa6-caf9bc021ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_22cf4933-eb5e-4c3d-a969-37bdb21d10ec" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_44800189-fb19-4c39-bfa6-caf9bc021ca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e089a554-d99c-4491-afa2-7978f1e5f7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_351f46e5-ecbc-4acb-82bc-42df446268ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e089a554-d99c-4491-afa2-7978f1e5f7ed" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_351f46e5-ecbc-4acb-82bc-42df446268ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_807cc6db-eb55-49ac-be60-18f4f9b7237c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e089a554-d99c-4491-afa2-7978f1e5f7ed" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_807cc6db-eb55-49ac-be60-18f4f9b7237c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_019d3edb-5946-7215-ab1e-7c31ac8845fa" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_e089a554-d99c-4491-afa2-7978f1e5f7ed" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_019d3edb-5946-7215-ab1e-7c31ac8845fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8444f8a3-66c0-44f5-b733-7522c7e9f8ca" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_667770e7-6d1f-492d-8bd0-4ce9a52c852f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8444f8a3-66c0-44f5-b733-7522c7e9f8ca" xlink:to="loc_us-gaap_Liabilities_667770e7-6d1f-492d-8bd0-4ce9a52c852f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e87c3d48-677e-4f13-8b87-862a58d7c8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8444f8a3-66c0-44f5-b733-7522c7e9f8ca" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e87c3d48-677e-4f13-8b87-862a58d7c8e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ac15fe8f-a744-4ec3-9af0-03678fb70cad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8444f8a3-66c0-44f5-b733-7522c7e9f8ca" xlink:to="loc_us-gaap_StockholdersEquity_ac15fe8f-a744-4ec3-9af0-03678fb70cad" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/CONSOLIDATEDSTATEMENTOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="simple" xlink:href="cbio-20260331.xsd#CONSOLIDATEDSTATEMENTOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/CONSOLIDATEDSTATEMENTOFOPERATIONSANDCOMPREHENSIVELOSSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d432e-9261-7fc7-b22f-1ff72201ca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d432e-9261-7e88-9027-1794f06dad76" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d432e-9261-7fc7-b22f-1ff72201ca1a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d432e-9261-7e88-9027-1794f06dad76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d432e-9261-7ed9-8b88-94fbb2fbfe70" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019d432e-9261-7fc7-b22f-1ff72201ca1a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d432e-9261-7ed9-8b88-94fbb2fbfe70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d432e-9261-7369-b639-f64add94d159" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d432e-9261-7bdf-be07-9469029518d2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d432e-9261-7369-b639-f64add94d159" xlink:to="loc_us-gaap_NetIncomeLoss_019d432e-9261-7bdf-be07-9469029518d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d432e-9261-704f-b548-e045e8aee495" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeNonoperating_019d432e-9261-73c2-8142-46edd3aa95c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeNonoperating"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019d432e-9261-704f-b548-e045e8aee495" xlink:to="loc_us-gaap_InvestmentIncomeNonoperating_019d432e-9261-73c2-8142-46edd3aa95c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019d432e-9261-7720-b68d-aa0cf956596d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_019d432e-9261-704f-b548-e045e8aee495" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019d432e-9261-7720-b68d-aa0cf956596d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d432e-9261-7858-b2de-b8c67759a0a2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d432e-9261-7b1d-8faa-28262244c0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d432e-9261-7858-b2de-b8c67759a0a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d432e-9261-7b1d-8faa-28262244c0a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019d432e-9261-73d6-95f4-bcb702944390" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019d432e-9261-7858-b2de-b8c67759a0a2" xlink:to="loc_us-gaap_OperatingExpenses_019d432e-9261-73d6-95f4-bcb702944390" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d432e-9261-7a16-a7bf-9bedb5c6a528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019d973f-8506-7ea9-a1b7-1b98d4528fd1" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d432e-9261-7a16-a7bf-9bedb5c6a528" xlink:to="loc_us-gaap_OperatingIncomeLoss_019d973f-8506-7ea9-a1b7-1b98d4528fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_019d432e-9261-7e7d-897e-802c80534864" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d432e-9261-7a16-a7bf-9bedb5c6a528" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_019d432e-9261-7e7d-897e-802c80534864" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="simple" xlink:href="cbio-20260331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUNAUDITED" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670d84e9-96d3-48be-af9c-8099d7f76528" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019d4396-d7d8-725c-946e-4c7d5a7ca230" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670d84e9-96d3-48be-af9c-8099d7f76528" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_019d4396-d7d8-725c-946e-4c7d5a7ca230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3818a7d4-b229-488c-adcb-93a2d5a5f3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_670d84e9-96d3-48be-af9c-8099d7f76528" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_3818a7d4-b229-488c-adcb-93a2d5a5f3a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7e8ba0d9-9ab6-43df-83fb-7e75631c9b84" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_NetIncomeLoss_7e8ba0d9-9ab6-43df-83fb-7e75631c9b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_2284c322-2399-47ff-8c9e-e9245f5bc024" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_ShareBasedCompensation_2284c322-2399-47ff-8c9e-e9245f5bc024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e28b3738-1b05-4142-858c-61a6fc560624" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_Depreciation_e28b3738-1b05-4142-858c-61a6fc560624" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseOther_05eb57d8-9dec-4c0f-a1a0-c287ec9ab1ff" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_InterestExpenseOther_05eb57d8-9dec-4c0f-a1a0-c287ec9ab1ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_544a7408-748e-4494-9874-44f2a093090b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_544a7408-748e-4494-9874-44f2a093090b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_42d7da85-9129-46ce-9113-088a5d016402" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_42d7da85-9129-46ce-9113-088a5d016402" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8ebc7a29-2cf6-4072-8760-353649f810cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_8ebc7a29-2cf6-4072-8760-353649f810cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_aae87770-6514-42c4-9efd-69d6e80cedb7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_aae87770-6514-42c4-9efd-69d6e80cedb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5d9505f8-ac2a-49fc-bd50-ff4550a78275" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5d9505f8-ac2a-49fc-bd50-ff4550a78275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_fa129937-1be5-4d37-acf1-85c252514685" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_fa129937-1be5-4d37-acf1-85c252514685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d8338e0f-eb3e-4fe4-93b7-c5ec847d093f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d8338e0f-eb3e-4fe4-93b7-c5ec847d093f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019d4396-8806-78ce-9523-cde6c604a027" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_019d4396-8806-78ce-9523-cde6c604a027" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019d4396-8806-700b-96e5-510a4d54043a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_69a88a34-ad01-4f67-ad4f-9222a5aba210" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_019d4396-8806-700b-96e5-510a4d54043a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a96096e-7327-4cdd-8850-5edb3f983984" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_594405fb-3a50-4226-9c51-265314c72bea" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a96096e-7327-4cdd-8850-5edb3f983984" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_594405fb-3a50-4226-9c51-265314c72bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe7e703e-7686-4b2e-8e41-c1d61d232e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a96096e-7327-4cdd-8850-5edb3f983984" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe7e703e-7686-4b2e-8e41-c1d61d232e0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f25c8-cefd-4bcb-97db-b6bde20ca127" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a96096e-7327-4cdd-8850-5edb3f983984" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_779f25c8-cefd-4bcb-97db-b6bde20ca127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69640292-fb72-4e67-92e0-98efda09dadd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_9b39c4ca-f2ae-4765-9238-d629ad543b0e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69640292-fb72-4e67-92e0-98efda09dadd" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_9b39c4ca-f2ae-4765-9238-d629ad543b0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_019d4397-db29-702b-8b7a-8d892dbfef60" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69640292-fb72-4e67-92e0-98efda09dadd" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_019d4397-db29-702b-8b7a-8d892dbfef60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PaymentOfDeferredOfferingCosts_019d4397-db29-7033-8077-cf43d22f8304" xlink:href="cbio-20260331.xsd#cbio_PaymentOfDeferredOfferingCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69640292-fb72-4e67-92e0-98efda09dadd" xlink:to="loc_cbio_PaymentOfDeferredOfferingCosts_019d4397-db29-7033-8077-cf43d22f8304" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/RestrictedCashDetails" xlink:type="simple" xlink:href="cbio-20260331.xsd#RestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/RestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_445d864f-b243-4c4d-85c0-850120555ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_95f489bf-7df8-4d93-81cc-628ca6386886" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_445d864f-b243-4c4d-85c0-850120555ee2" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_95f489bf-7df8-4d93-81cc-628ca6386886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_fdd92059-d69d-4d55-bb3d-d3a658ddb411" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_445d864f-b243-4c4d-85c0-850120555ee2" xlink:to="loc_us-gaap_RestrictedCash_fdd92059-d69d-4d55-bb3d-d3a658ddb411" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="cbio-20260331.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_019d43b5-7864-7611-abbb-411d5c5bba11" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PrepaidResearchAndDevelopmentExpenseCurrent_019d43b5-7864-7fe2-b9b7-cbc95f9df7f5" xlink:href="cbio-20260331.xsd#cbio_PrepaidResearchAndDevelopmentExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_019d43b5-7864-7611-abbb-411d5c5bba11" xlink:to="loc_cbio_PrepaidResearchAndDevelopmentExpenseCurrent_019d43b5-7864-7fe2-b9b7-cbc95f9df7f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_OtherPrepaidExpensesAndOtherCurrentAssets_019d43b5-7864-79bf-bbc6-b68edf638f37" xlink:href="cbio-20260331.xsd#cbio_OtherPrepaidExpensesAndOtherCurrentAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsCurrent_019d43b5-7864-7611-abbb-411d5c5bba11" xlink:to="loc_cbio_OtherPrepaidExpensesAndOtherCurrentAssets_019d43b5-7864-79bf-bbc6-b68edf638f37" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="cbio-20260331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9d7be3e8-2226-4b97-88a5-03c0b49a58fc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_AccruedResearchAndDevelopmentCurrent_357a5e2d-fb15-4dcf-9ba1-1ed432274141" xlink:href="cbio-20260331.xsd#cbio_AccruedResearchAndDevelopmentCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9d7be3e8-2226-4b97-88a5-03c0b49a58fc" xlink:to="loc_cbio_AccruedResearchAndDevelopmentCurrent_357a5e2d-fb15-4dcf-9ba1-1ed432274141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_1df3d8c3-90a8-4f6f-b8ce-4d2ea8dfe1c7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9d7be3e8-2226-4b97-88a5-03c0b49a58fc" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_1df3d8c3-90a8-4f6f-b8ce-4d2ea8dfe1c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_13c1767b-5002-48e0-b237-bbaf852a3e23" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9d7be3e8-2226-4b97-88a5-03c0b49a58fc" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_13c1767b-5002-48e0-b237-bbaf852a3e23" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_019d43bd-506f-774e-9724-05c8c50ab89c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_9d7be3e8-2226-4b97-88a5-03c0b49a58fc" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_019d43bd-506f-774e-9724-05c8c50ab89c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/LicenseAgreementsExpensesRelatedDevelopmentCostsDetails" xlink:type="simple" xlink:href="cbio-20260331.xsd#LicenseAgreementsExpensesRelatedDevelopmentCostsDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/LicenseAgreementsExpensesRelatedDevelopmentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_019d448b-22ae-7ec4-a267-5a0b1c13b15c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d448b-22ae-7f45-a995-e2e46874e71b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_019d448b-22ae-7ec4-a267-5a0b1c13b15c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d448b-22ae-7f45-a995-e2e46874e71b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_019d448b-22ae-7a18-a00d-eb0865bb3574" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingCostsAndExpenses_019d448b-22ae-7ec4-a267-5a0b1c13b15c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_019d448b-22ae-7a18-a00d-eb0865bb3574" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails" xlink:type="simple" xlink:href="cbio-20260331.xsd#LeasesOperatingLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96c67912-84fd-47ed-95a6-33e246ca5599" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_72b0b8a3-9c0e-4282-b4a3-16f7b5ac81cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96c67912-84fd-47ed-95a6-33e246ca5599" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_72b0b8a3-9c0e-4282-b4a3-16f7b5ac81cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d6dbbfd9-bd20-40fa-83e4-4654b39c5616" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96c67912-84fd-47ed-95a6-33e246ca5599" xlink:to="loc_us-gaap_OperatingLeaseLiability_d6dbbfd9-bd20-40fa-83e4-4654b39c5616" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails_1" xlink:type="simple" xlink:href="cbio-20260331.xsd#LeasesOperatingLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/LeasesOperatingLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_31f6627a-d8f2-4845-9608-87f00698f308" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ff63b8ae-2820-4f73-8483-cffcd07f5610" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_31f6627a-d8f2-4845-9608-87f00698f308" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ff63b8ae-2820-4f73-8483-cffcd07f5610" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c29fe1a0-b1e6-4093-84f7-7d05a45aa18d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_31f6627a-d8f2-4845-9608-87f00698f308" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c29fe1a0-b1e6-4093-84f7-7d05a45aa18d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ee51a3a2-1c84-4c91-bcf0-71cad9c67c99" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_31f6627a-d8f2-4845-9608-87f00698f308" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_ee51a3a2-1c84-4c91-bcf0-71cad9c67c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d9744-4efc-7f4c-9e28-75e3bbb578b8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_31f6627a-d8f2-4845-9608-87f00698f308" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_019d9744-4efc-7f4c-9e28-75e3bbb578b8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://crescentbiopharma.com/role/SegmentReportingSegmentLossIncludingSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="cbio-20260331.xsd#SegmentReportingSegmentLossIncludingSignificantSegmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://crescentbiopharma.com/role/SegmentReportingSegmentLossIncludingSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d44db-8bb1-7f08-b06d-5e816a5fa98e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d44db-8bb1-7f08-b06d-5e816a5fa98e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d44db-8bb1-7575-894a-c13940097e31" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d44db-8bb1-7575-894a-c13940097e31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PersonnelCosts_019d44db-8bb1-7bf5-b25c-00d346cb65e1" xlink:href="cbio-20260331.xsd#cbio_PersonnelCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:to="loc_cbio_PersonnelCosts_019d44db-8bb1-7bf5-b25c-00d346cb65e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_MilestoneAndLicenseFees_019d44db-8bb1-7096-ba9e-734faff3a8d9" xlink:href="cbio-20260331.xsd#cbio_MilestoneAndLicenseFees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:to="loc_cbio_MilestoneAndLicenseFees_019d44db-8bb1-7096-ba9e-734faff3a8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019d44db-8bb1-7511-849f-6e9b1666ea01" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:to="loc_us-gaap_ProfessionalFees_019d44db-8bb1-7511-849f-6e9b1666ea01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d44db-8bb1-7349-a84a-d7bc9b0fa9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019d44db-8bb1-7d9c-aae7-8d4d8751f8cc" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d44db-8bb1-7349-a84a-d7bc9b0fa9dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d44db-8bb1-7c2d-aaf3-661ef0742d86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_019d44db-8bb1-7c2d-aaf3-661ef0742d86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_019d44db-8bb1-7d94-b226-31bb4fb8eaaf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_019d44db-8bb1-7d94-b226-31bb4fb8eaaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_PersonnelCosts_019d44db-8bb1-7732-9e9a-5d08ee569d4e" xlink:href="cbio-20260331.xsd#cbio_PersonnelCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:to="loc_cbio_PersonnelCosts_019d44db-8bb1-7732-9e9a-5d08ee569d4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cbio_MilestoneAndLicenseFees_019d44db-8bb1-7f44-aff3-47052f702572" xlink:href="cbio-20260331.xsd#cbio_MilestoneAndLicenseFees"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:to="loc_cbio_MilestoneAndLicenseFees_019d44db-8bb1-7f44-aff3-47052f702572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_019d44db-8bb1-71a3-90e2-ec77cf9aac80" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:to="loc_us-gaap_ProfessionalFees_019d44db-8bb1-71a3-90e2-ec77cf9aac80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019d44db-8bb1-77c5-97d6-f34ceb65d5c4" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019d44db-8bb1-7086-8f9d-f62e8593643e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019d44db-8bb1-77c5-97d6-f34ceb65d5c4" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
